Graeme Archer

Full central neurokinin-1 receptor blockade is required for efficacy in depression: evidence from orvepitant clinical studies

Emiliangelo Ratti, P. Bettica, Robert Alexander et al. · Journal of Psychopharmacology · 2013 · 67 citations

Results From 2 Randomized, Double-Blind, Placebo-Controlled Studies of the Novel NK1 Receptor Antagonist Casopitant in Patients With Major Depressive Disorder

Emiliangelo Ratti, Kevin M. Bellew, P. Bettica et al. · Journal of Clinical Psychopharmacology · 2011 · 64 citations

Psychiatry, Functional Selectivity, Medicine +14

Efficacy of Vestipitant, A Neurokinin-1 Receptor Antagonist, in Primary Insomnia

Emiliangelo Ratti, David Carpenter, Stefano Zamuner et al. · SLEEP · 2013 · 46 citations · Full text

Recommendations for the Application of Biostatistical Methods during the Development and Validation of Alternative Toxicological Methods

Hermann−Georg Holzhütter, Graeme Archer, Nadia Dami et al. · Alternatives to Laboratory Animals · 1996 · 37 citations

Medical Toxicology, Toxicology Testing, Environmental Health +16

Analysis of gene mutations and clastogenicity following short-term treatment with azathioprine in Muta?Mouse

Catherine C. Smith, Graeme Archer, Emma J. Forster et al. · Environmental and Molecular Mutagenesis · 1999 · 28 citations